Mertkaya Aras

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 12

Top Topics

Positive Breast Cancer

Glycemic Control

Signaling Pathway

Top Venues

Cancer research

Turkish journal of haematology : official journal of Turkish Society of Haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, Meral Uner, Ozge Akbulut-Caliskan, Metin Cetin, Mertkaya Aras, Kubra Ibis, Burcu Çalışkan, Erden Banoglu, Stefan Wiemann, Aysegül Uner, Sercan Aksoy, Shikhar Mehrotra, Özgür Sahin
Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer. Cancer research 84 (9) (2024)
Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, Meral Uner, Ozge Akbulut-Caliskan, Metin Cetin, Mertkaya Aras, Kubra Ibis, Burcu Çalışkan, Erden Banoglu, Stefan Wiemann, Aysegül Uner, Sercan Aksoy, Shikhar Mehrotra, Özgür Sahin
Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer. Cancer research 84 (9) (2024)
Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, Meral Uner, Ozge Akbulut-Caliskan, Metin Cetin, Mertkaya Aras, Kubra Ibis, Burcu Çalışkan, Erden Banoglu, Stefan Wiemann, Aysegül Uner, Sercan Aksoy, Shikhar Mehrotra, Özgür Sahin
Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer. Cancer research 84 (9) (2024)
Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, Meral Uner, Ozge Akbulut-Caliskan, Metin Cetin, Mertkaya Aras, Kubra Ibis, Burcu Çalışkan, Erden Banoglu, Stefan Wiemann, Aysegül Uner, Sercan Aksoy, Shikhar Mehrotra, Özgür Sahin
Targeting TACC3 induces immunogenic cell death and enhances T-DM1 response in HER2-positive breast cancer. Cancer research (2024)
Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, Meral Uner, Ozge Akbulut-Caliskan, Metin Cetin, Mertkaya Aras, Kubra Ibis, Burcu Çalışkan, Erden Banoglu, Stefan Wiemann, Aysegül Uner, Sercan Aksoy, Shikhar Mehrotra, Özgür Sahin
Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer. Cancer research 84 (9) (2024)
Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, Meral Uner, Ozge Akbulut-Caliskan, Metin Cetin, Mertkaya Aras, Kubra Ibis, Burcu Çalışkan, Erden Banoglu, Stefan Wiemann, Aysegül Uner, Sercan Aksoy, Shikhar Mehrotra, Özgür Sahin
Targeting TACC3 induces immunogenic cell death and enhances T-DM1 response in HER2-positive breast cancer. Cancer research (2024)
Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, Meral Uner, Ozge Akbulut-Caliskan, Metin Cetin, Mertkaya Aras, Kubra Ibis, Burcu Çalışkan, Erden Banoglu, Stefan Wiemann, Aysegül Uner, Sercan Aksoy, Shikhar Mehrotra, Özgür Sahin
Targeting TACC3 induces immunogenic cell death and enhances T-DM1 response in HER2-positive breast cancer. Cancer research (2024)
Zeynep Sena Karahan, Mertkaya Aras, Tolga Sütlü
TCR-NK Cells: A Novel Source for Adoptive Immunotherapy of Cancer Turkish journal of haematology : official journal of Turkish Society of Haematology 40 (1) (2023)
Zeynep Sena Karahan, Mertkaya Aras, Tolga Sütlü
TCR-NK Cells: A Novel Source for Adoptive Immunotherapy of Cancer Turkish journal of haematology : official journal of Turkish Society of Haematology 40 (1) (2023)
Zeynep Sena Karahan, Mertkaya Aras, Tolga Sütlü
TCR-NK Cells: A Novel Source for Adoptive Immunotherapy of Cancer Turkish journal of haematology : official journal of Turkish Society of Haematology 40 (1) (2023)
Zeynep Sena Karahan, Mertkaya Aras, Tolga Sütlü
TCR-NK Cells: A Novel Source for Adoptive Immunotherapy of Cancer Turkish journal of haematology : official journal of Turkish Society of Haematology 40 (1) (2023)
Zeynep Sena Karahan, Mertkaya Aras, Tolga Sütlü
TCR-NK Cells: A Novel Source for Adoptive Immunotherapy of Cancer Turkish journal of haematology : official journal of Turkish Society of Haematology 40 (1) (2023)